RT Journal Article
SR Electronic
T1 Mathematical Analysis of a COVID-19 Epidemic Model by using Data Driven Epidemiological Parameters of Diseases Spread in India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.25.20079111
DO 10.1101/2020.04.25.20079111
A1 Pal, D.
A1 Ghosh, D.
A1 Santra, P.K.
A1 Mahapatra, G.S.
YR 2020
UL http://medrxiv.org/content/early/2020/04/29/2020.04.25.20079111.abstract
AB This paper attempts to describe the outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) via an epidemic model. This virus has dissimilar effects in different countries. The number of new active coronavirus cases is increasing gradually across the globe. India is now in the second stage of COVID-19 spreading, it will be an epidemic very quickly if proper protection is not undertaken based on the database of the transmission of the disease. This paper is using the current data of COVID-19 for the mathematical modeling and its dynamical analysis. We bring in a new representation to appraise and manage the outbreak of infectious disease COVID-19 through SEQIR pandemic model, which is based on the supposition that the infected but undetected by testing individuals are send to quarantine during the incubation period. During the incubation period if any individual be infected by COVID-19, then that confirmed infected individuals are isolated and the necessary treatments are arranged so that they cannot taint the other residents in the community. Dynamics of the SEQIR model is presented by basic reproduction number Ro and the comprehensive stability analysis. Numerical results are depicted through apt graphical appearances using the data of five states and India.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding is availableAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIndian Council of Medical research Ministry of Health and Family Welfare, Government of India 2020, https://www.icmr.nic.in/. https://www.mohfw.gov.in/